Fundraising FoxCatalio Capital Management, LP — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
PinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
BiotechDigital HealthFemTechIndianapolis, US
Richard T. Kloos(Chief Medical Officer)inTimothy McMeekan(Co-Founder, Chief Financial Officer, and Chief Business Officer)Giulia Kennedy(Founder)Isaac Ro(Director)inRisa Stack(Director)inEric Wang(Executive Officer)
Co-investorsBEVCBlue Venture FundsMountain Group CapitalSandbox Industries
ProSomnus offers oral appliance devices for treating obstructive sleep apnea and snoring, positioned as an alternative to CPAP machines.
Digital HealthHealthtechMedical DevicesWellness & FitnessPleasanton, US
Leonard Liptak(Executive Officer, Director)Sung Kim(Executive Officer)Jason Orchard(Director)Steven Pacelli(Director)Heather Rider(Director)Laing Rikkers(Executive Officer, Director)
Co-investorsCatalio Capital ManagementSpring Mountain Capital
Septerna is a biotechnology company that uses its proprietary Native Complex Platform to discover and develop oral small molecule therapies targeting GPCRs for endocrinology, immunology and inflammation, and metabolic diseases.
AI & Machine LearningBiotechDeep TechSouth San Francisco, US
Robert Lefkowitz(Founder)Arthur Christopoulos(Founder)Patrick Sexton(Founder)Ran Xiao(Executive Officer)inElizabeth Bhatt(Executive Officer)Samira Shaikhly(Executive Officer)in
Co-investorsRA CapitalSamsara BioCapitalVertex Ventures HCThird Rock Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.